March 2020: Efficacy of Deep Brain Stimulation for Obsessive-Compulsive Disorder

03/01/20 • 19 min

Executive Editor Michael Roy speaks with Damiaan Denys, M.D., Ph.D., and Ilse Graat, M.D., about their research on the tolerability and effectiveness of deep brain stimulation (DBS) for patients with refractory obsessive-compulsive disorder (OCD).

What characterizes OCD, and how widespread is it? [2:35]
What treatment with DBS involves [4:07]
Outline of study methods [6:25]
Why the part of the brain studied is relevant for DBS, and description of the scales used to measure how well the treatment worked [7:54]
Main findings with regard to response of OCD symptoms in patients who received DBS [10:51]
Discussion of adverse events [12:40]
Implications of the work for researchers, clinicians, and other mental health professionals [14:54]
What further studies should explore with regard to treatment with DBS [15:43]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online. Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue.

Follow the Journal on Twitter.

E-mail us at [email protected]

What characterizes OCD, and how widespread is it? [2:35]
What treatment with DBS involves [4:07]
Outline of study methods [6:25]
Why the part of the brain studied is relevant for DBS, and description of the scales used to measure how well the treatment worked [7:54]
Main findings with regard to response of OCD symptoms in patients who received DBS [10:51]
Discussion of adverse events [12:40]
Implications of the work for researchers, clinicians, and other mental health professionals [14:54]
What further studies should explore with regard to treatment with DBS [15:43]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online. Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue.

Follow the Journal on Twitter.

E-mail us at [email protected]

Previous Episode

February 2020: Adverse Outcomes Following Buprenorphine Discontinuation

Executive Editor Michael Roy speaks with Arthur Robin Williams, M.D., M.B.E., and Mark Olfson, M.D., M.P.H., about their research on adverse health outcomes following discontinuation of buprenorphine among Medicaid beneficiaries who were retained for variable periods beyond 6 months.

How buprenorphine helps patients, and factors affecting the use of this medication [2:50]
Are there any quality measures for buprenorphine or for the treatment of opioid use disorder more generally? [7:48]
What the authors aimed to achieve in the study [10:59]
How the authors determined what methods to use in the study [13:51]
Main findings with regard to adverse health outcomes after patients discontinued buprenorphine [16:22]
Implications of the results [19:01]
What further studies should explore with regard to treatment for opioid use disorder [21:50]
Takeaways for researchers, clinicians, and other mental health professionals [23:06]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online. Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue.

Follow the Journal on Twitter.

E-mail us at [email protected]

Next Episode

April 2020: Incidence of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic Disorder

Executive Editor Michael Roy speaks with Sarah A. Sullivan, Ph.D., and Stanley Zammit, Ph.D., about their research on the incidence, course, and outcome of psychotic experiences from childhood through early adulthood in the general population, and the prediction of psychotic disorder.

How common are psychotic experiences in the general population, and what burdens do they place on public health systems? [2:19]
What kinds of services are available to identify and treat individuals who have psychotic experiences? [3:48]
Study methods [5:33]
What kind of psychotic experiences were reported? [7:41]
Age as a significant factor [8:57]
Prediction of psychotic disorder by age 24 [10:33]
Implications for practicing clinicians and other mental health professionals [11:58]
Limitations of the study [12:41]
What other studies should explore regarding first-episode psychosis [13:52]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online. Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue.

Follow the Journal on Twitter.

E-mail us at [email protected]